Oral Vancomycin Effect in Primary Sclerosing Cholangitis

被引：0
|
作者：
Khan, Ruben [1 ]
Albugeaey, Mohammed [2 ]
Rangnekar, Amol S. [3 ]
机构：
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
[2] MedStar Georgetown Univ Hosp, Dept Gastroenterol, Washington, DC USA
[3] MedStar Georgetown Univ Hosp, Dept Hepatol, Washington, DC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-00911
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
911
引用
收藏
页码：S393 / S393
页数：1
相关论文
共 50 条
  • [31] Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis
    de Chambrun, Guillaume Pineton
    Nachury, Maria
    Funakoshi, Natalie
    Gerard, Romain
    Bismuth, Michael
    Valats, Jean-Christophe
    Panaro, Fabrizio
    Navarro, Francis
    Desreumaux, Pierre
    Pariente, Benjamin
    Blanc, Pierre
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (10) : 1247 - 1252
  • [32] Single Center Experience of Oral Vancomycin Therapy in Young Patients with Primary Sclerosing Cholangitis: A Case Series
    Alenchery, Amala J.
    Patel, Sophia
    Mahajan, Lori
    Kurowski, Jacob A.
    Worley, Sarah
    Hupertz, Vera
    Radhakrishnan, Kaddakal
    Kabbany, Mohammad Nasser
    LIVERS, 2023, 3 (01): : 93 - 104
  • [33] Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis
    Dao, Alexander
    Abidian, Mohamed
    Lestrange, Aimee
    Mattar, Mark
    Rangnekar, Amol
    Charabaty, Aline
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (07) : E90 - E91
  • [34] Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis
    Ali, Ahmad H.
    Buness, Cynthia W.
    Fischer, Ryan
    Holtmann, Gerald J.
    Shah, Ayesha
    Lewindon, Peter
    Shah, Shamita
    Ragnekar, Amol S.
    Taylor, Amy E.
    Goel, Aparna
    Cox, Kenneth L.
    Alrabadi, Leina
    Wadsworth, Steve
    Kulkarni, Sakil S.
    Lindor, Keith D.
    HEPATOLOGY, 2023, 77 (06) : E174 - E175
  • [35] Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis
    Damman, J. L.
    Rodriguez, E. A.
    Ali, A. H.
    Buness, C. W.
    Cox, K. L.
    Carey, E. J.
    Lindor, K. D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (07) : 886 - 895
  • [36] IMPACT OF VANCOMYCIN ON LIVER FIBROSIS IN PAEDIATRIC PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Staudohar, Stefania
    Beedie, Taylor
    Miller, Michael
    Zizzo, Andreanne
    HEPATOLOGY, 2024, 80 : S1858 - S1859
  • [37] Concurrent oral lichen planus and primary sclerosing cholangitis
    Tong, DC
    Ferguson, MM
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 356 - 358
  • [38] Oral pirfenidone in the treatment of primary sclerosing cholangitis.
    Angulo, P
    MacCarty, RL
    Sylvestre, PB
    Jorgensen, RA
    LaRusso, NF
    Lindor, KD
    GASTROENTEROLOGY, 2000, 118 (04) : A1015 - A1015
  • [39] Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis
    Ali, Ahmad Hassan
    Damman, Jennifer
    Shah, Shamita B.
    Davies, Yinka
    Hurwitz, Melissa
    Stephen, Mariam
    Lemos, Leta M.
    Carey, Elizabeth J.
    Lindor, Keith D.
    Buness, Cynthia W.
    Alrabadi, Leina
    Berquist, William E.
    Cox, Kenneth L.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (08) : 941 - 950
  • [40] Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis
    Tan, Li-Zsa
    Reilly, Claire R.
    Steward-Harrison, Lana C.
    Balouch, Fariha
    Muir, Richard
    Lewindon, Peter J.
    GUT, 2019, 68 (08) : 1533 - +
12345